These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 26017019

  • 1. Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation.
    Cheuk DK, Chiang AK, Ha SY, Chan GC.
    Cochrane Database Syst Rev; 2015 May 27; 2015(5):CD009311. PubMed ID: 26017019
    [Abstract] [Full Text] [Related]

  • 2. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
    Dignan FL, Wynn RF, Hadzic N, Karani J, Quaglia A, Pagliuca A, Veys P, Potter MN, Haemato-oncology Task Force of British Committee for Standards in Haematology, British Society for Blood and Marrow Transplantation.
    Br J Haematol; 2013 Nov 27; 163(4):444-57. PubMed ID: 24102514
    [Abstract] [Full Text] [Related]

  • 3. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.
    Fisher SA, Cutler A, Doree C, Brunskill SJ, Stanworth SJ, Navarrete C, Girdlestone J.
    Cochrane Database Syst Rev; 2019 Jan 30; 1(1):CD009768. PubMed ID: 30697701
    [Abstract] [Full Text] [Related]

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 5. Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non-cardiac surgery or invasive procedures.
    Huber J, Stanworth SJ, Doree C, Fortin PM, Trivella M, Brunskill SJ, Hopewell S, Wilkinson KL, Estcourt LJ.
    Cochrane Database Syst Rev; 2019 Nov 28; 11(11):CD012745. PubMed ID: 31778223
    [Abstract] [Full Text] [Related]

  • 6. Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children.
    Qureshi A, Marshall L, Lancaster D.
    Pediatr Blood Cancer; 2008 Apr 28; 50(4):831-2. PubMed ID: 18286502
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation.
    Tay J, Tinmouth A, Fergusson D, Huebsch L, Allan DS.
    Biol Blood Marrow Transplant; 2007 Feb 28; 13(2):206-17. PubMed ID: 17241926
    [Abstract] [Full Text] [Related]

  • 16. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.
    Rank CU, Lynggaard LS, Als-Nielsen B, Stock W, Toft N, Nielsen OJ, Frandsen TL, Tuckuviene R, Schmiegelow K.
    Cochrane Database Syst Rev; 2020 Oct 10; 10(10):CD013399. PubMed ID: 33038027
    [Abstract] [Full Text] [Related]

  • 17. Ursodeoxycholic acid for primary biliary cirrhosis.
    Rudic JS, Poropat G, Krstic MN, Bjelakovic G, Gluud C.
    Cochrane Database Syst Rev; 2012 Dec 12; 12(12):CD000551. PubMed ID: 23235576
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.
    Amaral FC, Baptista-Silva JC, Nakano LC, Flumignan RL.
    Cochrane Database Syst Rev; 2022 Nov 22; 11(11):CD013683. PubMed ID: 36413425
    [Abstract] [Full Text] [Related]

  • 19. Prophylactic low-dose heparin or prostaglandin E1 may prevent severe veno-occlusive disease of the liver after allogeneic hematopoietic stem cell transplantation in Korean children.
    Song JS, Seo JJ, Moon HN, Ghim T, Im HJ.
    J Korean Med Sci; 2006 Oct 22; 21(5):897-903. PubMed ID: 17043426
    [Abstract] [Full Text] [Related]

  • 20. Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
    Richardson PG, Smith AR, Triplett BM, Kernan NA, Grupp SA, Antin JH, Lehmann L, Shore T, Iacobelli M, Miloslavsky M, Hume R, Hannah AL, Nejadnik B, Soiffer RJ, Defibrotide Study Group.
    Biol Blood Marrow Transplant; 2017 Jun 22; 23(6):997-1004. PubMed ID: 28285079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.